An analysis of transfusion practice and the role of intraoperative red blood cell salvage during cesarean delivery

被引:61
作者
Fong, Jill
Gurewitsch, Edith D.
Kang, Hey-Joo
Kump, Lisa
Mack, Patricia Fogarty
机构
[1] New York Presbyterian Hosp, Weill Cornell Med Ctr, Dept Anesthesiol, New York, NY 10021 USA
[2] New York Presbyterian Hosp, Weill Cornell Med Ctr, Dept Obstet & Gynecol, New York, NY 10021 USA
[3] Johns Hopkins Univ, Sch Med, Dept Obstet & Gynecol, Baltimore, MD 21218 USA
[4] NYU, Sch Med, Dept Obstet & Gynecol, New York, NY 10012 USA
关键词
D O I
10.1213/01.ane.0000253232.45403.e5
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
BACKGROUND: We sought to determine to what extent intraoperative salvaged red blood cells (RBC) might theoretically reduce exposure to appropriately transfused allogenic erythrocytes in Cesarean delivery patients. METHODS: Medical records of Cesarean delivery patients requiring blood transfusions from January 1, 1992 to June 30, 1996 and June 1, 1998 to June 30, 2003 were reviewed. For each patient, we calculated the number of allogenic RBC units that could have theoretically been avoided had intraoperative autotransfusion been performed, based upon estimated blood loss, preoperative hematocrit, and the amount of retrieved blood needed to yield a single RBC unit. RBC transfusion appropriateness was determined using the recommended guideline of transfusing RBCs if the hemoglobin is < 7 gm/dL in a patient with continuing bleeding. RESULTS: A small percentage of Cesarean delivery patients (1.8%) received blood product transfusions. Of 207 patients receiving blood transfusions, salvaged erythrocytes could have theoretically decreased exposure to allogenic RBCs in 115 (55.6%) patients. Only 75.7% of these 115 patients were appropriately transfused with erythrocytes. CONCLUSION: Theoretically, based on best, average, and worst RBC salvage recovery calculations, 25.1%, 21.2%, or 14.5% of the appropriately transfused patients, respectively, could have completely avoided allogenic RBC transfusion.
引用
收藏
页码:666 / 672
页数:7
相关论文
共 27 条
[1]   The ability of the Haemonetics(R) 4 cell saver system to remove tissue factor from blood contaminated with amniotic fluid [J].
Bernstein, HH ;
Rosenblatt, MA ;
Gettes, M ;
Lockwood, C .
ANESTHESIA AND ANALGESIA, 1997, 85 (04) :831-833
[2]   USE OF THE CELL SAVER IN PATIENTS WITH SICKLE-CELL TRAIT [J].
BRAJTBORD, D ;
JOHNSON, D ;
RAMSAY, M ;
PAULSEN, W ;
SWYGERT, T ;
RAMON, V ;
HARGIS, D .
ANESTHESIOLOGY, 1989, 70 (05) :878-879
[3]   Cell salvage in obstetrics: the time has come [J].
Catling, S ;
Joels, L .
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2005, 112 (02) :131-132
[4]   Clinical experience with cell salvage in obstetrics: 4 cases from one UK centre [J].
Catling, SJ ;
Freites, O ;
Krishnan, S ;
Gibbs, R .
INTERNATIONAL JOURNAL OF OBSTETRIC ANESTHESIA, 2002, 11 (02) :128-134
[5]  
CHEEK TG, 1993, ANESTHESIA OBSTET, P7
[6]   Adverse reactions associated with autologous blood transfusion: Evaluation and incidence at a large academic hospital [J].
Domen, RE .
TRANSFUSION, 1998, 38 (03) :296-300
[7]   INTRAOPERATIVE BLOOD-LOSS DURING ELECTIVE LOWER SEGMENT CESAREAN-SECTION [J].
DUTHIE, SJ ;
GHOSH, A ;
NG, A ;
HO, PC .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1992, 99 (05) :364-367
[8]   Blood transfusion in obstetrics and gynaecology [J].
Ekeroma, AJ ;
Ansari, A ;
Stirrat, GM .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1997, 104 (03) :278-284
[9]   Clearance of fetal products and subsequent immunoreactivity of blood salvaged at cesarean delivery [J].
Fong, J ;
Gurewitsch, ED ;
Kump, L ;
Klein, R .
OBSTETRICS AND GYNECOLOGY, 1999, 93 (06) :968-972
[10]   A SIMPLIFIED DEVICE FOR INTRAOPERATIVE AUTO-TRANSFUSION [J].
GRIMES, DA .
OBSTETRICS AND GYNECOLOGY, 1988, 72 (06) :947-950